Insider Moves: HEICO, Pegasystems, Transdigm, Cytokinetics, LKQ

Insiders have been trading these 5 stocks: ((HEI)), ((PEGA)), ((TDG)), ((CYTK)) and ((LKQ)). Here is a breakdown of their recent trades and their value.

In recent transactions, HEICO has seen significant activity from its directors. Director Frank Schwitter sold 600 shares, amounting to $142,812, while Director Julie Neitzel parted with 700 shares for $172,361. The most substantial transaction came from Director Alan Schriesheim, who sold a whopping 50,000 shares, netting $11,978,500. These sales highlight a notable shift in insider holdings at HEICO.

Pegasystems also experienced notable insider sales. CPO Rifat Kerim Akgonul sold 6,000 shares, bringing in $537,240. Additionally, VP of Finance & CAO Efstathios Kouninis sold 658 shares for $59,154. These transactions suggest a strategic realignment or profit-taking by key executives within Pegasystems.

Transdigm Group saw a significant transaction from Co-COO Joel Reiss, who sold 3,300 shares for a total of $4,361,919. This sale indicates a substantial divestment by a high-ranking executive, which could be interpreted as a move to capitalize on the current stock valuation.

Cytokinetics witnessed insider sales from EVP of Research & Development Fady Ibraham Malik, who sold 2,000 shares for $76,220, and Director Wendall Wierenga, who sold 20,000 shares for $769,200. These transactions may reflect a strategic decision by insiders to adjust their holdings in the company.

In contrast to the sales seen in other companies, LKQ’s President & CEO Justin Jude made a notable purchase, acquiring 2,708 shares for $100,168. This purchase might signal confidence in the company’s future prospects and a commitment to increasing personal investment in LKQ.